NEW YORK, April 21, 2014 /PRNewswire/ -- Dr. Brian Mehling, CMO of Blue Horizon International (BHI) spoke at a forum, "Stem Cell Treatments and the Potential for Public Health," last month at the Dubai International Convention and Exhibition Centre, UAE. The event provided a unique setting for companies in the medical travel industry to showcase services and facilitated a target audience of medical travel professionals including physicians, patients, purchasers, facilitators, and insurance companies.
"Stem cells are the future of medicine and we believe their role in treatments will become the preferred substitutes for many surgical, pharmacological, and rehabilitative medical services," Dr. Mehling said. "This expo provides an opportunity for BHI to educate and raise awareness on an international stage. It is an informative and important discussion on the revolutionary changes in the treatment of many chronic conditions, disorders, and acute diseases."
Key conference issues at IMTEC included: patient safety and quality of care, legal and ethical aspects of medical travel, market trends, and the future of medical tourism.
BHI is a healthcare consulting company with a unique mission that combines cutting-edge stem cell therapies to emerging markets and philanthropy to the underserved. Its subsidiaries have safely and efficiently performed and documented more than 2,000 stem cell therapy procedures on over 600 patients worldwide. Its charity arm, Blue Horizon Charitable Foundation, donates treatments to eligible patients. For more information, visit www.bluehorizonstemcells.com.
PRLog ID: www.prlog.org/12278935
SOURCE Blue Horizon International